Abstract
Summary
Using computed tomography (CT), we found the decreases in bone size of vertebrae and femur, cortical bone area (CBA) of femur and bone density (BD) of vertebrae in prepubertal female with Turner syndrome (TS) compared to those of controls.
Introduction
Bone mineral density results from previous studies utilizing single-photon absorptiometry (SPA) or dual-energy X-ray absorptiometry (DXA) in children with TS are controversial. The present study used CT to assess the differences in cancellous and cortical bone size and BD between prepubertal TS patients prior to growth hormone therapy and historical age and ethnicity-matched female controls.
Methods
Anthropometrics and CT bone measurements including cross-sectional area (CSA) and BD of lumbar vertebrae and femur and CBA of femur in prepubertal TS females were reviewed and compared with those in controls.
Results
Twenty-two prepubertal TS patients had delayed bone age, were shorter and lighter than controls (Ps < 0.001). After adjusting for weight, height and skeletal age, vertebral BD and CBA of the femur were lower in patients than in controls (P < 0.001 and P = 0.021, respectively). However, after additional adjusting for puberty, results were not different from controls. While a positive correlation between vertebral BD and age was noted in controls (r = 0.367, P = 0.092), a significant negative correlation was noted in patients (r = −0.615, P = 0.002).
Conclusions
While the decrease in vertebrae and femur sizes of patients with TS appeared to be secondary to their small body size, the decreased BD of vertebrae and CBA of femur were likely secondary to estrogen deficiency.
Similar content being viewed by others
References
Finby N, Archibald RM (1963) Skeletal abnormalities associated with gonadal dysgenesis. Am J Roentgenol 89:1222–1235
Smith MA, Wilson J, Price WH (1982) Bone demineralization in patients with Turner’s syndrome. J Med Genet 19:100–103
Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ (1982) Skeletal demineralization in Turner’s syndrome. Calcif Tissue Int 34:519–522
Davies MC, Guleki B, Jacobs HS (1995) Osteoporosis in Turner’s syndrome and other forms of primary amenorrhoea. Clin Endocrinol (Oxf) 43:741–746
Landin-Wilhelmsen K, Bryman I, Windh M, Wilhelmsen L (1999) Osteoporosis and fractures in Turner syndrome-importance of growth promoting and oestrogen therapy. Clin Endocrinol (Oxf) 51:497–502
Gravholt CH, Vestergaard P, Hermann AP, Mosekilde L, Brixen K, Christiansen S (2003) Increased fracture rates in Turner’s syndrome: a nationwide questionnaire survey. Clin Endocrinol (Oxf) 59:89–96
Shaw NJ, Rehan VK, Husain S, Marshall T, Smith CS (1997) Bone mineral density in Turner’s syndrome—a longitudinal study. Clin Endocrinol (Oxf) 47:367–370
Zuckerman-Levin N, Yaniv I, Schwartz T, Guttmann H, Hochberg Z (2007) Normal DXA bone mineral density but frail cortical bone in Turner’s syndrome. Clin Endocrinol (Oxf) 67:60–64
Costa AM, Lemos-Marini SH, Baptista MT, Morcillo AM, Maciel-Guerra AT, Guerra G Jr (2002) Bone mineralization in Turner syndrome: a transverse study of the determinant factors in 58 patients. J Bone Miner Metab 20:294–297
Mora S, Weber G, Guarneri MP, Nizzoli G, Pasolini D, Chiumello G (1992) Effect of estrogen replacement therapy on bone mineral content in girls with Turner syndrome. Obstet Gynecol 5:747–751
Gafni RI, Baron J (2004) Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy x-ray absorptiometry (DEXA). J Pediatr 144:253–257
Pitukcheewanont P, Chen P (2005) Bone density measurements in children and adolescents: quantitative computed tomography versus dual-energy x-ray absorptiometry. The Endocrinologist 15:232–239
Lanes R, Gunczler P, Paoli M, Weisinger JR (1995) Bone mineral density of prepubertal age girls with Turner’s syndrome while on growth hormone therapy. Horm Res 44:168–171
Neely EK, Marcus R, Rosenfeld RG, Bachrach LK (1993) Turner syndrome adolescents receiving growth hormone are not osteopenic. J Clin Endocrinol Metab 76:861–866
Högler W, Briody J, Moore B, Garnett S, Lu PW, Cowell CT (2004) Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry. J Clin Endocrinol Metab 89:193–199
Bechtold S, Rauch F, Noelle V, Donhauser S, Neu CM, Schoenau E, Schwarz HP (2001) Musculoskeletal analyses of the forearm in young women with Turner syndrome: a study using peripheral quantitative computed tomography. J Clin Endocrinol Metab 86:5819–5823
Wren TA, Liu X, Pitukcheewanont P, Gilsanz V (2005) Bone densitometry in pediatric populations: discrepancies in the diagnosis of osteoporosis by DXA and CT. J Pediatr 146:776–779
Pitukcheewanont P, Safani D, Church J, Gilsanz V (2005) Bone measures in HIV-1 infected children and adolescents: disparity between quantitative computed tomography and dual-energy x-ray absorptiometry measurements. Osteoporos Int 16:1393–1396
Hanton L, Axelrod L, Bakalov V, Bondy CA (2003) The importance of estrogen replacement in young women with Turner syndrome. J Women’s Health (Larchmt) 12:971–977
Nanao K, Tsuchiya Y, Kotoh S, Hasegawa Y (2002) Low vertebral cancellous bone density in peripubertal girls with Turner’s syndrome and boys with hypogonadism. J Pediatr Endocrinol Metab 15:1537–1542
Tanner JM (1978) Physical growth and development. In: Forfar JO, Arnell CC (eds) Textbook of pediatrics, 2nd edn. Churchill Livingstone, Edinburgh, pp 249–303
Numbenjapon N, Costin G, Gilsanz V, Pitukcheewanont P (2007) Low cortical bone density measured by computed tomography in children and adolescents with untreated hyperthyroidism. J Pediatr 150:527–530
Wren TA, Kim PS, Janicka A, Sanchez M, Gilsanz V (2007) Timing of peak bone mass: discrepancies between CT and DXA. J Clin Endocrinol Metab 92:938–941
Wu T, Mendola P, Buck GM (2002) Ethnic differences in the presence of secondary sex characteristics and menarche among US girls: the Third National Health and Nutrition Examination Survey, 1988–1994. Pediatrics 110:752–757
Carrascosa A, Gussinye M, Terradas P, Yeste D, Audi L, Vincens-Calvet E (2000) Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients. J Bone Miner Res 15:2005–2010
Seeman E (2001) Sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metab 86:4576–4584
Lu PW, Cowell CT, Lloyd-Jones SA, Broidy J, Howman-Giles R (1996) Volumetric bone mineral density in normal subjects, aged 5–27 years. J Clin Endocrinol Metab 81:1586–1590
Mora S, Pitukcheewanont P, Kaufman FR, Nelson JC, Gilsanz V (1999) Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development. J Bone Miner Res 14:1664–71
Bagi CM, Ammann P, Rizzoli R, Miller SC (1997) Effect of estrogen deficiency on cancellous and cortical bone structure and strength of the femoral neck in rats. Calcif Tissue Int 61:336–344
Sybert VP, McCauley E (2004) Turner’s syndrome. New Engl J Med 351:1227–1238
Reiter EO, Blethen SL, Baptista J, Price L (2001) Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner’s syndrome. J Clin Endocrinol Metab 86:1936–1941
Acknowledgments
The authors would like to thank Frederick Dorey, Ph.D. for his support in statistical analysis and Norma Castaneda for her assistance in data collection. This study was partially supported by research grants from EMD Serono, Inc.
Conflicts of interest
N.N., D.S, S.R., V.S., and G.C. have nothing to declare. P.P. is currently on the speakers bureau for EMD, Serono, Inc., Genentech, Inc., Endo Phamaceuticals, Inc. and serves as a consultant/advisor to Serono, Inc.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pitukcheewanont, P., Numbenjapon, N., Safani, D. et al. Bone size and density measurements in prepubertal children with Turner syndrome prior to growth hormone therapy. Osteoporos Int 22, 1709–1715 (2011). https://doi.org/10.1007/s00198-010-1375-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-010-1375-2